10-Q: The Joint Corp. Reports Q3 2024 Results Amid Strategic Shift to Re-Franchising

The Joint Corp. announced its Q3 2024 financial results, highlighting a strategic move to re-franchise the majority of its company-owned clinics.

Summary

• The Joint Corp. reported a net loss of $3.2 million for the third quarter of 2024, compared to a net loss of $0.7 million in the same period last year.
• Total revenue for the quarter was $30.2 million, a 2.5% increase year-over-year, driven by growth in franchise operations.
• The company is actively pursuing a strategy to re-franchise most of its company-owned clinics, aiming to leverage its franchising capabilities for long-term growth.
• System-wide comparable sales increased by 4% for clinics open at least 13 months, while mature clinics open 48 months or more saw a decrease of 2%.
• The company ended the quarter with 963 clinics in operation, including 838 franchised and 125 company-owned or managed clinics.
• Adjusted EBITDA for the quarter was $2.4 million, compared to $2.9 million in the same period last year.
• The company has $20.7 million in cash and cash equivalents and $20 million available under its line of credit.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While there is positive growth in franchise operations and system-wide sales, the company is reporting a net loss and is facing significant challenges. The strategic shift to re-franchising is a positive long-term move, but the current financial results and risks temper the overall sentiment.

Positives

• System-wide sales for all clinics increased by 8% year-over-year.
• Franchise operations continue to expand, with 838 clinics in operation.
• The company has a solid cash position with $20.7 million in cash and cash equivalents and $20 million available under its line of credit.
• The company is actively re-franchising its corporate clinics, which is expected to drive long-term growth.

Negatives

• The company reported a net loss of $3.2 million for the quarter.
• Revenues from company-owned or managed clinics decreased by 1.9% year-over-year.
• Mature clinics open 48 months or more saw a decrease of 2% in comparable sales.
• Adjusted EBITDA decreased to $2.4 million from $2.9 million in the same period last year.
• The company incurred $1.5 million in litigation expenses related to employment matters.

Risks

• The company faces risks from unfavorable global economic and political conditions, including the Ukraine War and the Israel-Gaza conflict.
• Labor shortages and inflation are impacting the company's ability to recruit chiropractors and increasing operating costs.
• The company's growth strategy may be hindered if franchisees cannot secure appropriate clinic locations or attract patients.
• The company has limited experience operating company-owned clinics in certain geographic areas.
• The company has previously identified material weaknesses in its internal controls over financial reporting.
• The company may not be able to continue to sell franchises to qualified franchisees.
• The chiropractic industry is highly competitive.
• New regulations regarding joint employer responsibility could negatively impact the franchise business model.
• The company's IT security systems may be breached.
• The delayed filing of a quarterly report has made the company ineligible to use a registration statement on Form S-3.

Future Outlook

The company expects to use or redeploy its cash resources to support the business within the context of prevailing market conditions, which could rapidly and materially deteriorate or otherwise change. The company aims to generate significant processes that will provide value creating capital allocation opportunities, including reinvestment in the brand, IT platforms, repurchase of regional development territories, and/or a stock repurchase program.

Management Comments

• The company seeks to be the leading provider of chiropractic care in the markets it serves and to become the most recognized brand in the industry.
• The company believes that it continues to have a sound business concept and will benefit from the fundamental changes taking place in the manner in which Americans access chiropractic care.
• The company's refined strategy will leverage its greatest strength its capacity to build a franchise to drive long-term growth for both its franchisees and The Joint as a public company.

Industry Context

The Joint Corp. operates in the competitive chiropractic industry, facing challenges from well-established independent competitors. The company's shift to re-franchising aligns with a broader trend of businesses focusing on core competencies and leveraging franchise models for growth. The company is also navigating the changing landscape of healthcare access and consumer preferences for natural wellness solutions.

Comparison to Industry Standards

• While the document does not provide specific industry benchmarks, comparable companies in the healthcare franchise space include those in the dental, fitness, and personal care sectors.
• The Joint Corp.'s comparable sales growth of 4% is a key metric to compare against industry averages, which can vary widely depending on the specific sector and economic conditions.
• The company's focus on re-franchising is a strategic move that can be compared to other franchise businesses that have divested corporate-owned locations to focus on franchise growth.
• The company's adjusted EBITDA of $2.4 million for the quarter is a key metric to compare against other similar sized healthcare franchise businesses.
• The company's cash position of $20.7 million and $20 million available under its line of credit is a key metric to compare against other similar sized healthcare franchise businesses.

Management Changes

Legal Proceedings

• The company entered into settlement agreements from litigation related to employment matters of $1.5 million.
• Ongoing litigation related to a medical injury claim has progressed to mediation with a range of possible settlement outcomes between $0.9 million and $6.0 million.

Related Party Transactions

• The company sold franchise licenses to family members and a co-partner of Mr. Jefferson Gramm, a beneficial holder of more than 5% of the company's outstanding common stock.
• Mr. Gramm loaned approximately $370,000 to an unaffiliated franchisee.
• The company owes Mr. Gramm $375,000 for professional service costs incurred during the chief executive search, which was fully reimbursed on October 31, 2024.

Stakeholder Impact

• Shareholders may be concerned about the net loss and the strategic shift to re-franchising.
• Franchisees may benefit from the company's focus on franchise growth and support.
• Employees may be affected by the company's cost-cutting measures and the re-franchising of company-owned clinics.
• Customers may experience changes in service as the company transitions to a franchise-focused model.

Next Steps

• The company will continue to execute its re-franchising strategy.
• The company will focus on reinvesting in the brand, IT platforms, and potentially repurchasing regional development territories or initiating a stock repurchase program.
• The company will continue to monitor and address the impact of global economic and political conditions, labor shortages, and inflation.

Key Dates

Keywords

chiropractic, franchise, clinics, re-franchising, revenue, EBITDA, sales, healthcare, marketing, regional developer